Date of event: unknown.The date received by manufacturer has been used as a default a device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.There is no 510(k) for this device as it is manufactured outside the us and not sold in the us but is considered to be substantially similar to the legally u.S.Marketed device bd bbl" sabouraud dextrose agar with chloramphenicol and gentamicin deep fill catalog number 296359 which is a class 1, 510(k) exempt device.
|
H6: investigation summary: this statement is to summarize findings on the recent complaint 3171962 against sabouraud agar with gentamicin and chloramphenicol, catalog number 254096, lot number 1112582.Event description: it was reported that the plates were found to be contaminated in their unopened sleeves.Complaint history review: complaint history of the affected batch and catalog number was reviewed for the past 12 months.There were no similar complaints registered.Therefore a trend could not be identified.Dhr review: the bhr was reviewed.No deviations from validated processes were registered.Furthermore the affected batch met all required release specifications and no deviation was registered during qc release testing.Sterilization record review: the medium itself is heat sterilized.However, this product is filled under aseptic conditions.Since a 100 % control for sterility is not possible a representative sampling is done by the qc department.Lot no.1112582 complied to our internal acceptance quality limit (aql) for sterility.Sample analysis: a picture sample was not provided for further evaluation.A picture sample was not provided for further evaluation.Investigation conclusion: aseptic manufacturing processes are unable to guarantee sterility of the given product.Since a 100 % inspection is not possible for aseptic products, sterility testing carried out on the basis of a representative sample.Therefore, occasional contamination cannot be prevented.Nevertheless, to improve customer experience, an interdisciplinary team was founded to further reduce the occurrence of these subliminal contaminations.Effectiveness checks indicate a significant improvement to the situation caused by the triggered actions.Bd will continue to monitor incoming complaints for similar defect types.Evaluation results: based on the internal investigation and as no pictures were provided, the complaint was not confirmed.Neither a trend nor a definite root cause could not be identified.
|